Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations
Open Access
- 1 August 2014
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 99 (8) , E1510-E1518
Abstract
Context: Many children with idiopathic short stature have a delayed bone age. Idiopathic short stature with advanced bone age is far less common. Objective: The aim was to identify underlying genetic causes of short stature with advanced bone age. Setting and Design: We used whole-exome sequencing to study three families with autosomal-dominant short stature, advanced bone age, and premature growth cessation. Results: Affected individuals presented with short stature [adult heights −2.3 to −4.2 standard deviation scores (SDS)] with histories of early growth cessation or childhood short stature (height SDS −1.9 to −3.5 SDS), advancement of bone age, and normal endocrine evaluations. Whole-exome sequencing identified novel heterozygous variants in ACAN, which encodes aggrecan, a proteoglycan in the extracellular matrix of growth plate and other cartilaginous tissues. The variants were present in all affected, but in no unaffected, family members. In Family 1, a novel frameshift mutation in exon 3 (c.272delA) was identified, which is predicted to cause early truncation of the aggrecan protein. In Family 2, a base-pair substitution was found in a highly conserved location within a splice donor site (c.2026+1G>A), which is also likely to alter the amino acid sequence of a large portion of the protein. In Family 3, a missense variant (c.7064T>C) in exon 14 affects a highly conserved residue (L2355P) and is strongly predicted to perturb protein function. Conclusions: Our study demonstrates that heterozygous mutations in ACAN can cause a mild skeletal dysplasia, which presents clinically as short stature with advanced bone age. The accelerating effect on skeletal maturation has not previously been noted in the few prior reports of human ACAN mutations. Our findings thus expand the spectrum of ACAN defects and provide a new molecular genetic etiology for the unusual child who presents with short stature and accelerated skeletal maturation.Keywords
This publication has 33 references indexed in Scilit:
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Endocrine Regulation of the Growth PlateHormone Research in Paediatrics, 2005
- A Mutation in the Variable Repeat Region of the Aggrecan Gene (AGC1) Causes a Form of Spondyloepiphyseal Dysplasia Associated with Severe, Premature OsteoarthritisThe American Journal of Human Genetics, 2005
- Developmental regulation of the growth plateNature, 2003
- Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndromeNature Genetics, 1997
- The versican C-type lectin domain recognizes the adhesion protein tenascin-R.Proceedings of the National Academy of Sciences, 1995
- Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytesMicroscopy Research and Technique, 1994
- Spondyloepiphyseal dysplasia, mild autosomal dominant type is not due to primary defects of type II collagenAmerican Journal of Medical Genetics, 1990
- Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats.The Journal of Physiology, 1989
- Attributes of the radiographic standard of reference for the National Health Examination SurveyAmerican Journal of Physical Anthropology, 1971